Risk Factors of Pulmonary Fungal Infections in Breast Cancer Patients and the Clinical Treatment

蒋一玲,陈占红,方红明,黄健,顾枫琳,王晓稼
2013-01-01
Abstract:OBJECTIVE To investigate the risk factors of pulmonary fungal infections in breast cancer patients so as to provide reliable basis for the clinical diagnosis and treatment.METHODS The clinical data of 184 cases of breast cancer patients who were treated in the hospital from Jan 2009 to Dec 2011 were retrospectively analyzed,the risk factors of the pulmonary fungal infections in the breast cancer patients were statistically analyzed,and the efficacy of the clinical treatment was observed.RESULTS Of 184 cases of breast cancer patients,the pulmonary fugal infections occurred in 26 cases with the infection rate of 14.1%.Candida albicans was the predominant species of the pathogens,accounting for 65.4%.The univariate analysis showed that the pulmonary fungal infections were closely related to the tumor stage,white blood cell count,time of use of antibiotics(P0.05).After the treatment with itraconazole,there were 8 cases markedly effective,12 cases effective,and 6 cases invalid,with the effective rate of 76.9%.CONCLUSION The poor tumor stage,low count of white blood cell,and long-term use of antibiotics are the high-risk factors for the pulmonary fungal infections in the breast cancer patients,and itraconazole is an effective drug for the treatment of pulmonary fungal infections in the breast cancer patients.
What problem does this paper attempt to address?